Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine (Q100517411)

From Wikidata

Jump to navigation Jump to search

scientific article published on 08 October 2020

Language	Label	Description	Also known as
English	Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine	scientific article published on 08 October 2020

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33041105%20AND%20SRC:MED&resulttype=core&format=json

18 October 2020

Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33041105%20AND%20SRC:MED&resulttype=core&format=json

18 October 2020

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

6

object named as

Drew Weissman

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33041105%20AND%20SRC:MED&resulttype=core&format=json

18 October 2020

Harvey M. Friedman

7

object named as

Harvey M Friedman

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33041105%20AND%20SRC:MED&resulttype=core&format=json

18 October 2020

4

object named as

Norbert Pardi

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33041105%20AND%20SRC:MED&resulttype=core&format=json

18 October 2020

5

object named as

Gary H Cohen

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33041105%20AND%20SRC:MED&resulttype=core&format=json

18 October 2020

author name string

Philip C LaTourette

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33041105%20AND%20SRC:MED&resulttype=core&format=json

18 October 2020

Sita Awasthi

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33041105%20AND%20SRC:MED&resulttype=core&format=json

18 October 2020

Angela Desmond

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33041105%20AND%20SRC:MED&resulttype=core&format=json

18 October 2020

publication date

8 October 2020

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33041105%20AND%20SRC:MED&resulttype=core&format=json

18 October 2020

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33041105%20AND%20SRC:MED&resulttype=core&format=json

18 October 2020

First estimates of the global and regional incidence of neonatal herpes infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.09.079

7 January 2021

Neonatal herpes simplex infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.09.079

7 January 2021

Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.09.079

7 January 2021

Effectiveness of maternal influenza immunization in mothers and infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.09.079

7 January 2021

Maternal immunization confers protection against neonatal herpes simplex mortality and behavioral morbidity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.09.079

7 January 2021

Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.09.079

7 January 2021

An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.09.079

7 January 2021

Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.09.079

7 January 2021

Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.09.079

7 January 2021

Trivalent glycoprotein subunit vaccine prevents neonatal herpes simplex virus mortality and morbidity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.09.079

7 January 2021

mRNA vaccines - a new era in vaccinology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.09.079

7 January 2021

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.09.079

7 January 2021

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.09.079

7 January 2021

Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.09.079

7 January 2021

Protection of newborn mice against herpes simplex virus infection by prenatal and postnatal transmission of antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.09.079

7 January 2021

Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.09.079

7 January 2021

Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.09.079

7 January 2021

Identifiers

10.1016/J.VACCINE.2020.09.079

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33041105%20AND%20SRC:MED&resulttype=core&format=json

18 October 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33041105%20AND%20SRC:MED&resulttype=core&format=json

18 October 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33041105%20AND%20SRC:MED&resulttype=core&format=json

18 October 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q100517411&oldid=1984686946"